ArticleCPT: pharmacometrics & systems pharmacology2025

Model-Informed Drug Development for Ligelizumab in Patients With Chronic Spontaneous Urticaria.

Andrzej Bienczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.